Trademark: CENYX BIOTECH 2278762
Word
CENYX BIOTECH
ID
2278762
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
29 April 2022
Registration Date
29 April 2022
Renewal Date
29 April 2032
Owner(s)
Service
PHILLIPS ORMONDE FITZPATRICK
Goods and Services:
Class 5:
Diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; veterinary preparations; radio-isotope markers for therapeutic or diagnostic use; in vitro diagnostic preparations for medical purposes; vaccines; contrast media for use in medical imaging; contrast media for in vivo imaging; drug delivery agents that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the prevention of inflammatory disorders; non-prescription medicines; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; medicament formulating agents; biological preparations for medical or veterinary purposes; pharmaceuticals; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of cardiovascular disease; drug delivery agents; pharmaceutical preparations for the treatment of inflammatory diseases; antibodies for medical purposes.
Diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; veterinary preparations; radio-isotope markers for therapeutic or diagnostic use; in vitro diagnostic preparations for medical purposes; vaccines; contrast media for use in medical imaging; contrast media for in vivo imaging; drug delivery agents that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the prevention of inflammatory disorders; non-prescription medicines; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; medicament formulating agents; biological preparations for medical or veterinary purposes; pharmaceuticals; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of cardiovascular disease; drug delivery agents; pharmaceutical preparations for the treatment of inflammatory diseases; antibodies for medical purposes.